Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials
Public ClinicalTrials.gov record NCT01428063. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Re-Treatment Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Subjects With Chronic Hepatitis C
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to provide anti-hepatitis C virus drugs to patients who received placebo + peginterferon alfa-2a + ribavirin in prior Bristol-Myers Squibb (BMS) studies and determine whether addition of these drugs results in higher cure rates in patients who previously failed therapy. Approximately 100 genotype 1b patients who received placebo in BMS study NCT01428063 (AI447-028) will receive active drugs in this study.
Study identification
- NCT ID
- NCT01428063
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 276 participants
Conditions and interventions
Conditions
Interventions
- Daclatasvir Drug
- Asunaprevir Drug
- Pegylated interferon alfa-2a Drug
- Ribavirin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2011 (Type not available)
- Primary completion
- Sep 2014 (Actual)
- Completion
- Dec 2014 (Actual)
- Last update posted
- May 27, 2016
2011 – 2014
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Baptist Medical Center South | Montgomery | Alabama | 36116 | — |
| Scripps Clinic | La Jolla | California | 92037 | — |
| Scpmg/ Kaiser Permanente Los Angeles Medical Center | Los Angeles | California | 90027 | — |
| University Of Colorado Denver And Hospital | Aurora | Colorado | 80045 | — |
| Yale University School Of Medicine | New Haven | Connecticut | 06520 | — |
| Uf Hepatology Research At Ctrb | Gainesville | Florida | 32610 | — |
| Schiff Center For Liver Diseases | Miami | Florida | 33136 | — |
| Mercy Medical Center | Baltimore | Maryland | 21202 | — |
| Digestive Disease Associates, P.A. | Catonsville | Maryland | 21228 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Washington University School Of Medicine | St Louis | Missouri | 63110 | — |
| North Shore Long Island Jewish Health System | Manhasset | New York | 11030 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Options Health Research, Llc | Tulsa | Oklahoma | 74104 | — |
| University Of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Nashville Medical Research Institute | Nashville | Tennessee | 37205 | — |
| Baylor College Of Medicine | Houston | Texas | 77030 | — |
| Alamo Medical Research | San Antonio | Texas | 78215 | — |
| Metropolitan Research | Fairfax | Virginia | 22031 | — |
| Dean Clinic | Madison | Wisconsin | 53715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 86 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01428063, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 27, 2016 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01428063 live on ClinicalTrials.gov.